Drug-tunable multidimensional synthetic gene control using inducible degron-tagged dCas9 effectors
Deactivated Cas9 fused to transactivation domains can be used to control gene expression, however its presence can prevent rapid switching between different regulatory states. Here the authors generate conditionally degradable dCas9 and Cpf1 proteins for multidimensional control of functional activi...
Main Authors: | Dirk A. Kleinjan, Caroline Wardrope, Si Nga Sou, Susan J. Rosser |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-10-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-017-01222-y |
Similar Items
-
Engineering Synthetic Signaling Pathways with Programmable dCas9-Based Chimeric Receptors
by: Toni A. Baeumler, et al.
Published: (2017-09-01) -
Epigenetic Targeting of Granulin in Hepatoma Cells by Synthetic CRISPR dCas9 Epi-suppressors
by: Hong Wang, et al.
Published: (2018-06-01) -
Synergistic Upregulation of Target Genes by TET1 and VP64 in the dCas9–SunTag Platform
by: Sumiyo Morita, et al.
Published: (2020-02-01) -
A modular degron library for synthetic circuits in mammalian cells
by: Hélène Chassin, et al.
Published: (2019-05-01) -
Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner
by: Henriette O’Geen, et al.
Published: (2019-05-01)